Decision Biomarkers Closes Shop, Files for Bankruptcy | GenomeWeb

NEW YORK (GenomeWeb News) – Protein biomarker technology firm Decision Biomarkers has closed up shop and filed for Chapter 7 bankruptcy.

Decision, based in Waltham, Mass., filed for bankruptcy on Dec. 22 in US Bankruptcy Court in Boston. Decision's website indicates that the company had closed its doors as of Dec. 2, 2009.

"There are several companies interested in the technology and we are hopeful the business will be reconstituted in the near future," Decision said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.